rA (Bz), 2'-OMe AMP CPG
CPG for the incorporation of a 2'-O-methyl modified ribo-A nucleobase at the 3' end of an oligonucleotide.
CPG for the incorporation of a 2'-O-methyl modified ribo-A nucleobase at the 3' end of an oligonucleotide.
CPG column for incorporation of an (otherwise unmodified) reverse (5' to 3') dT nucleobase at the 3' end of an oligonucleotide.
Phosphoramidite for incorporation of a 2'-fluoro-modified ribo-G nucleobase within an oligonucleotide
CPG column for the incorporation of an (otherwise unmodified) reverse (5' to 3') dA nucleobase at the 3' end of an oligonucleotide.
Phosphoramidite for incorporation of an (otherwise unmodified) reverse (5’ to 3’) dG nucleobase within an oligonucleotide.
CPG column for incorporation of a 2'-fluoro modified U nucleobase at the 3' end of an oligonucleotide.
CPG column for incorporation of a 2'-O-methyl modified ribo-C nucleobase at the 3' end of an oligonucleotide.
CPG for the incorporation of an (otherwise unmodified) reverse (5' to 3') dC nucleobase at the 3' end of an oligonucleotide.
CPG for the incorporation of a 2'-fluoro modified ribo-A nucleobase at the 3' end of an oligonucleotide.
CPG for incorporation of a 2'-fluoro modified ribo-G nucleobase at the 3' end of an oligonucleotide
Europe, Middle East, and Africa | |
---|---|
UK | +44 1992 470 757 |
Germany | +49 30 5304 2200 |
North America, Latin America | |
Wisconsin, USA | +1 888 575 9695 |
Asia Pacific | |
China | +8621-22509000 |
Singapore | +65 6734 4800 |